Literature DB >> 1086323

Proliferation of murine thymic lymphocytes in vitro is mediated by the concanavalin A-induced release of a lymphokine (costimulator).

V Paetkau, G Mills, S Gerhart, V Monticone.   

Abstract

Mitogen-induced proliferation of lymphocytes may in theory result directly from the interaction of mitogen with the cells, or indirectly as a result of the mitogen-stimulated release of lymphokines. In the case of murine thymic lymphocytes exposed to concanavalin A (Con A) in tissue culture, we have determined that mitogenesis depends upon a lymphokine. Interaction of the thymic lymphocytes with lectin is necessary, but not sufficient, for mitogenesis. A lymphokine, or costimulator for mitogenesis, is released by normal spleen or thymus cells during the first 16 hr of their exposure to Con A, and in the presence of a phytomitogen it stimulates thymic mitogenesis. Under conditions of low costimulator levels, no mitogenesis follows the interaction of Con A with cells. The response of adult CBA/J mouse thymocytes to phytohemagglutinin (PHA) is very low, compared to their response to Con A. When costimulator is added to PHA, the cells respond as well as they do to Con A. Costimulator does not act through Con A-binding sites on thymus cells. Its production is dependent on both cells carrying omega surface antigen (T lymphocytes) and adherent cells of the macrophage-monocyte series. The adherent population, but not the T cells, may be heavily irradiated without affecting production of costimulator. Costimulator is not a mitogen on its own.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086323

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Historical origins of current IBD concepts.

Authors:  J B Kirsner
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 2.  T cell clones: their use for the study of specificity, induction, and effector-function of T cells.

Authors:  H von Boehmer; W Haas; H Pohlit; H Hengartner; M Nabholz
Journal:  Springer Semin Immunopathol       Date:  1980-05

3.  Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s).

Authors:  D W Talmage; J A Woolnough; H Hemmingsen; L Lopez; K J Lafferty
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 4.  Network regulation among T cells; conclusions from limiting dilution experiments.

Authors:  K Eichmann; K Fey; R Kuppers; I Melchers; M M Simon; H U Weltzien
Journal:  Springer Semin Immunopathol       Date:  1983

5.  Induction of T-cell maturation by a cloned line of thymic epithelium (TEPI).

Authors:  T R Beardsley; M Pierschbacher; G D Wetzel; E F Hays
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

Authors:  G Buchan; K Barrett; M Turner; D Chantry; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

7.  The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.

Authors:  E J Hancock; D G Kilburn
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

8.  A factor with interleukin-1-like activity is produced by peritoneal cells from the frog, Xenopus laevis.

Authors:  D Watkins; S C Parsons; N Cohen
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

9.  Quantitative absorption of interleukin-2 by peripheral blood and synovial fluid lymphocytes from patients with rheumatoid arthritis.

Authors:  C Knobloch; M Schlesier; R Dräger; M Gärtner; H H Peter
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

10.  Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis.

Authors:  A Shore; S Jaglal; E C Keystone
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.